Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.

Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.

BACKGROUND:The absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC) and neutrophil to lymphocyte ratio (NLR) are known markers of inflammation. We evaluated whether ANC, ALC, AMC and NLR, both before and after treatment with nivolumab, are indicative marker...

Full description

Bibliographic Details
Main Authors: Monica Khunger, Pradnya Dinkar Patil, Arjun Khunger, Manshi Li, Bo Hu, Sagar Rakshit, Arnab Basu, Nathan Pennell, James P Stevenson, Paul Elson, Tanmay S Panchabhai, Vamsidhar Velcheti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6201866?pdf=render

Internet

http://europepmc.org/articles/PMC6201866?pdf=render

Similar Items